Clinical Trial Update: Atrasentan in Treating Patients With Locally Recurrent or Metastatic Kidney Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for atrasentan in locally recurrent or metastatic kidney cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Cancer

Drugs mentioned

• atrastenan (atrasentan)

Snippet

Sponsor: Eastern Cooperative Oncology Group | Conditions: Kidney Cancer | Phase 2 | Status: COMPLETED